Trust Signals
Key Takeaways
- Yohimbine HCl is the only form with a verified, consistent dose per unit. Bark extract labels are unreliable for actual yohimbine content.
- The most cited human RCT for fat loss (Ostojic, 2006, n=20 soccer players) used roughly 20 mg per day in divided doses and found significant body fat reduction versus placebo over 21 days. Sample size is small.
- Yohimbine blocks alpha-2 adrenergic receptors, which are densely expressed in lower-body and abdominal fat depots, but this mechanism is completely blocked by elevated insulin. Fasted use is mechanistically essential, not optional.
- The FDA has issued safety advisories about yohimbe products adulterated with undisclosed active drugs. Third-party COA verification is not cosmetic caution, it is a basic safety step.
- PDE5 inhibitors outperform yohimbine for erectile dysfunction by a wide margin in head-to-head evidence. Yohimbine's strongest evidence niche is modest, fasted fat mobilization in already-lean individuals.
What Are the Best Yohimbine Supplements? (Direct Answer)
Table of Contents
What Does the Evidence Actually Say About Yohimbine?
The evidence base is thin but real. The most frequently cited controlled trial is Ostojic (2006), a double-blind RCT in 20 professional soccer players who received approximately 20 mg per day of yohimbine HCl in two divided doses versus placebo over 21 days. The yohimbine group showed a statistically significant reduction in body fat percentage. The study is small, uses a specific athletic population, and does not necessarily generalize to sedentary or obese individuals.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →For erectile dysfunction, a 1998 systematic review by Ernst and Pittler (published in the Journal of Urology) pooled data from seven RCTs and found yohimbine superior to placebo for psychogenic erectile dysfunction. Effect sizes were modest. No trial in that analysis would meet current regulatory standards for an ED drug.
| Claim | Best Evidence Type | Effect Direction | Confidence Rating |
|---|---|---|---|
| Modest fat loss in lean, exercising individuals | Small human RCT (Ostojic 2006, n=20) | Positive, small effect | Moderate |
| Improved psychogenic erectile dysfunction | Systematic review of small RCTs (Ernst & Pittler 1998) | Positive, modest effect | Moderate (low by modern standards) |
| Alpha-2 adrenergic receptor antagonism | Pharmacology lab data, receptor binding studies | Established mechanism | High (mechanism only) |
| Significant fat loss in overweight/sedentary adults | No adequate human RCT | Unclear | Very Low |
| Appetite suppression | Animal and anecdotal reports | Inconsistent | Very Low |
| Performance enhancement in athletes | Single small RCT, no replication | Positive signal, not replicated | Low |
How Does Yohimbine Work at the Receptor Level?
Yohimbine is a selective competitive antagonist at alpha-2 adrenergic receptors (primarily alpha-2A and alpha-2C subtypes). In fat tissue, presynaptic alpha-2 receptors normally act as a brake on norepinephrine release. By blocking them, yohimbine increases local norepinephrine spillover, which then activates beta-adrenergic receptors on adipocytes, upregulating hormone-sensitive lipase (HSL) and stimulating lipolysis (fatty acid release into circulation).
Alpha-2 receptors are expressed at particularly high density in lower-body subcutaneous fat depots (gluteal, femoral) and in visceral abdominal fat, which is one mechanistic reason why those depots are considered harder to mobilize and why yohimbine is specifically targeted at them in sports nutrition contexts. This receptor density difference is documented in pharmacology literature but does not automatically translate to clinically meaningful spot reduction in humans.
At central nervous system level, yohimbine also antagonizes alpha-2 receptors in the locus coeruleus, disinhibiting noradrenergic neurons and producing the anxiety, agitation, and tachycardia seen with excess dosing. This is the same mechanism exploited in anxiety research models. The oral bioavailability of yohimbine HCl is variable across individuals, with peak plasma levels typically reached within 1 to 2 hours of ingestion according to pharmacokinetic studies, and a plasma half-life in the range of roughly 0.5 to 1 hour for the parent compound, with active metabolites persisting longer. These exact figures depend on the study and population, and inter-individual variability is high.
What the mechanism does NOT prove: Demonstrating receptor antagonism and increased norepinephrine at a molecular level does not prove meaningful fat loss in free-living humans eating ad libitum. Mechanism plus one small RCT is not the same as replicated evidence.
How Do I Pick a High-Quality Yohimbine Supplement?
Three criteria separate a usable product from a gamble:
1. Form: HCl, not crude bark extract
Yohimbine HCl is the purified salt form. The molecular weight of yohimbine HCl is approximately 390 g/mol. Products listing "yohimbe bark extract" standardized to a percentage of "total alkaloids" or "yohimbines" (plural) may contain as little as a few percent actual yohimbine, with the rest composed of other corynantheidine-type alkaloids (rauwolscine, corynanthine, ajmalicine) that have different and sometimes opposing pharmacology.
2. Third-party certification
NSF Certified for Sport, Informed Sport, and USP Verified all require lot-specific testing by independent labs. These programs test for label accuracy, heavy metals, and in some cases, undisclosed drug adulterants. Given the FDA's documented findings of adulteration in yohimbe-containing products, third-party verification is a real safety requirement here, not marketing.
3. Dose per capsule in a useful range
Products dosed at 2.5 mg per capsule allow titration from low doses upward. Products containing 10 mg or more per capsule make it difficult to start safely. A product listing only a multi-ingredient "fat burning blend" with no individual yohimbine HCl mg stated is not useful, regardless of the brand.
What Do Most Yohimbine Pages Get Wrong?
This is the section competitor pages skip entirely.
Label dose versus actual dose: a documented problem
A 2016 study by Cohen et al. published in Drug Testing and Analysis analyzed yohimbe-containing supplements and found that yohimbine content varied dramatically from labeled claims, with some products containing far less than labeled and others containing substantially more. Products with the most inaccurate labels were often those using bark extract rather than isolated HCl. This is not a theoretical concern. It is a documented, published analytical finding.
Bark extract alkaloid interference
Rauwolscine (alpha-yohimbine) is an alpha-2 antagonist like yohimbine but with roughly higher CNS penetrance and greater risk of CNS side effects. Corynanthine has alpha-1 blocking activity, which partially opposes yohimbine's peripheral effects. When you take a crude bark extract, you are dosing an unpredictable mixture of all of these. The pharmacokinetic interaction between them in humans is not well characterized.
Insulin completely blocks the mechanism
Elevated insulin directly inhibits HSL activity and suppresses the beta-adrenergic signaling cascade that yohimbine depends on for fat mobilization. Taking yohimbine after a carbohydrate-containing meal or when insulin is elevated (including in insulin-resistant individuals at baseline) is mechanistically equivalent to taking it with a receptor-blocker co-administered. This is why virtually every positive yohimbine study uses fasted conditions, and why products that include yohimbine in a post-meal protein blend are wasting the dose.
Tolerance and cycling: no controlled human data
Anecdotal cycling recommendations (5 days on / 2 off, or 8 weeks on / 4 off) are widely repeated but based on receptor biology extrapolation, not human cycling trials. The receptor desensitization concern is real in principle but the optimal cycling protocol for humans has not been studied. Be appropriately skeptical of anyone giving you precise cycling numbers with high confidence.
Why Does Fasted Timing Matter Chemically?
When you eat carbohydrates, pancreatic beta cells release insulin. Insulin binds to its receptor on adipocytes and activates a signaling cascade (PI3K/Akt pathway) that phosphorylates and inactivates hormone-sensitive lipase, the enzyme yohimbine's mechanism depends on activating. Insulin also activates phosphodiesterase 3B, which degrades cyclic AMP, the second messenger that links beta-adrenergic receptor activation (produced by yohimbine's norepinephrine release) to HSL activation.
In practical terms, the entire downstream signaling chain yohimbine relies on is suppressed in the presence of meaningful insulin. This is not a "take it fasted for slightly better results" nuance. It is a biochemical gate: the mechanism is effectively closed when insulin is elevated. This means yohimbine taken with or shortly after a carbohydrate-containing meal has its primary fat-mobilization mechanism blocked regardless of how good the supplement quality is.
The rule of thumb is therefore: take yohimbine in a fasted state, ideally before exercise when catecholamine levels are already rising. The chemistry explains why this is not merely a bioavailability issue but a fundamental mechanistic requirement.
How Does Yohimbine Compare to Alternatives?
| Comparison | Yohimbine | Alternative | Verdict |
|---|---|---|---|
| Fat loss vs. caloric deficit alone | Small additive effect in lean athletes (1 small RCT) | Caloric deficit: large, replicated effect | Yohimbine loses. Deficit is irreplaceable. Yohimbine is at best marginal on top of it. |
| Fat loss vs. caffeine | Modest, mechanism limited by insulin | Caffeine: comparable beta-adrenergic stimulation, more evidence, lower side-effect burden | Caffeine has more and better evidence for thermogenesis. Yohimbine adds alpha-2 antagonism which caffeine lacks. |
| Erectile dysfunction vs. PDE5 inhibitors | Modest effect, systematic review of small RCTs | Sildenafil, tadalafil: large Phase III RCTs, FDA-approved | Yohimbine loses clearly. PDE5 inhibitors are categorically better supported. |
| Alpha-2 antagonism vs. prescription phentolamine | Oral, accessible, weaker and less selective | Phentolamine: non-selective alpha blocker, prescription, stronger | Phentolamine stronger but not indicated for fat loss. Different clinical contexts. |
| Bark extract vs. yohimbine HCl | HCl: accurate dose, defined pharmacology | Bark extract: underdosed, variable alkaloid profile | Yohimbine HCl wins on every quality metric. |
What Doses Are Used in Human Studies?
| Context | Dose Used | Protocol | Evidence Source | Notes |
|---|---|---|---|---|
| Fat loss (athletes) | Approximately 20 mg/day total | Two divided doses, fasted, 21 days | Ostojic 2006, n=20 | Small sample, athletic population only |
| Erectile dysfunction | Approximately 18 mg/day total | Three 6 mg doses per day | Ernst & Pittler systematic review 1998 | Pooled from 7 RCTs, variable protocols |
| Conservative starting dose | 2.5 mg to 5 mg | Single dose, fasted, assess tolerance | Clinical practice consensus | Not from a single RCT; for tolerability assessment |
| Weight-based dosing (research model) | Approximately 0.2 mg/kg body weight | Once or twice daily, fasted | Derived from pharmacokinetic modeling | Individual sensitivity varies widely |
How Do I Read a Yohimbine COA to Judge Product Quality?
A certificate of analysis is the single most important document for any yohimbine supplement. Here is what a legitimate COA must contain, and what to reject:
What a valid COA must show
- Compound identity stated precisely: "Yohimbine hydrochloride" not just "yohimbe" or "yohimbine alkaloids"
- Test method: HPLC (high-performance liquid chromatography) is the accepted analytical standard for alkaloid quantification. UV spectrophotometry alone is less specific.
- Result with units: Milligrams per capsule or milligrams per gram, not just a percentage of a blend
- Laboratory name and accreditation: The lab should be ISO 17025 accredited or equivalent. Named labs with published accreditation are verifiable.
- Lot number matching your product: A COA without a lot number is a generic marketing document, not a product-specific assay.
- Date of testing: Should be within the product's shelf life window
Reject if you see
- COA shows only microbiological testing, heavy metals, and no alkaloid identity or potency testing
- No named laboratory, or a lab name that does not appear in any publicly searchable accreditation database
- Result expressed only as "conforms to specification" without the numerical specification stated
- Percentage listed for a bark extract with no conversion to per-unit milligram content
What Are the Real Safety Concerns?
Yohimbine has a narrow therapeutic window relative to many other supplements. The FDA has received adverse event reports associated with yohimbe-containing products including heart attacks, hypertensive crisis, and death, though causality in individual cases is complicated by product adulteration and polypharmacy.
Absolute contraindications
- Current use of monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis
- Diagnosed anxiety disorder: yohimbine reliably worsens anxiety symptoms
- Uncontrolled hypertension or any cardiovascular disease
- Kidney disease: yohimbine and its metabolites are renally cleared
- Pregnancy or breastfeeding: no safety data
Drug interactions requiring caution
- Tricyclic antidepressants (additive adrenergic effects)
- Antihypertensive medications (yohimbine can blunt their effect or cause rebound hypertension)
- Other stimulants including ephedrine and high-dose caffeine (additive cardiovascular load)
- Clonidine (yohimbine directly reverses clonidine's alpha-2 agonist mechanism)
FAQ
What is the best yohimbine supplement for fat loss?
Isolated yohimbine HCl capsules from third-party tested brands (NSF, Informed Sport, or USP verified) are the best choice because the dose is verifiable. Look for products stating the exact milligram amount of yohimbine HCl per capsule, a published COA, and no proprietary blends that hide the actual dose.
How much yohimbine HCl should I take per day?
Human studies showing modest fat-loss effects have used roughly 0.2 mg per kg of body weight, typically 5 mg to 20 mg per day in divided doses. Start at 2.5 mg to 5 mg to assess cardiovascular and anxiety tolerance before increasing. Do not combine with stimulants or MAOIs.
Is yohimbine bark extract the same as yohimbine HCl?
No. Bark extract is a crude mixture containing yohimbine plus roughly 30 other alkaloids, some with opposing or unpredictable effects. Yohimbine HCl is the isolated, salt form with a defined dose. Bark extract labels listing only total alkaloid weight as a percentage do not tell you the actual yohimbine content.
Does yohimbine actually work for fat loss?
Evidence is Moderate at best. A small double-blind RCT by Ostojic (2006) in soccer players found significant fat reduction versus placebo. Most other positive findings come from small trials or animal studies. Effect size is modest and requires a caloric deficit to be meaningful. It does not work if insulin is chronically elevated.
What are the main side effects of yohimbine?
The most documented side effects are anxiety, elevated heart rate, hypertension, headache, and gastrointestinal upset. These are dose-dependent and mediated by central and peripheral noradrenergic stimulation. People with anxiety disorders, hypertension, or cardiovascular disease should avoid yohimbine entirely.
Can I stack yohimbine with caffeine?
Caffeine and yohimbine both raise norepinephrine and can have additive cardiovascular effects. Some pre-workout stacks combine them, but doing so increases anxiety and palpitation risk meaningfully. If you combine them, use the lowest effective dose of each and avoid entirely if you have any cardiac history.
How do I read a yohimbine supplement COA?
A valid COA should show: the specific compound tested (yohimbine HCl, not just 'yohimbe'), the test method (HPLC is preferred), the result in mg per unit or percentage, the testing laboratory name and accreditation, and the lot number matching your product. Reject any COA without a named accredited lab or a specific lot number.
Is yohimbine legal and safe?
In the United States, yohimbine is sold as a dietary supplement and is not FDA-approved as a drug. The FDA has issued warnings about yohimbine-containing products with undisclosed drug combinations. It is not on the WADA prohibited list for most sports but check your specific governing body. It is contraindicated with MAOIs.
Why does yohimbine stop working over time?
Alpha-2 adrenergic receptors can upregulate or desensitize with continuous exposure. Chronic yohimbine use may also raise basal cortisol, which counteracts fat mobilization. Most practitioners recommend cycling (5 days on, 2 days off, or 8 weeks on, 4 weeks off), though controlled cycling data in humans is limited.
What should I avoid combining with yohimbine?
Avoid MAOIs (risk of hypertensive crisis), tricyclic antidepressants, other stimulants (ephedrine, high-dose caffeine), and antihypertensive medications. High-carbohydrate meals raise insulin and blunt yohimbine's fat-mobilization effect, which is why fasted dosing is most common in protocols.
What makes a yohimbine supplement low quality?
Warning signs include: listing 'yohimbe bark extract' with only a percentage standardization and no HCl specification, no lot-specific COA, inclusion in a proprietary blend where total weight is listed but individual doses are hidden, no third-party verification logo, and claims of 'enhanced bioavailability' without published data.
Does yohimbine help with erectile dysfunction?
There is older evidence from small RCTs suggesting yohimbine may modestly improve psychogenic erectile dysfunction by blocking alpha-2 receptors and increasing penile blood flow. However, effect sizes were small and PDE5 inhibitors (sildenafil, tadalafil) have vastly superior evidence. Yohimbine is not a clinical first-line treatment for ED.
Sources
- Ostojic SM. "Yohimbine: the effects on body composition and exercise performance in soccer players." Research in Sports Medicine. 2006;14(4):289-299.
- Ernst E, Pittler MH. "Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials." Journal of Urology. 1998;159(2):433-436.
- Cohen PA, et al. "Quantity of yohimbine and rauwolscine in dietary supplements." Drug Testing and Analysis. 2016;8(3-4):357-369.
- U.S. Food and Drug Administration. "Tainted Products Marketed as Dietary Supplements." FDA.gov. (Ongoing advisory database, accessed 2026.)
- Goldberg MR, Robertson D. "Yohimbine: a pharmacological probe for study of the alpha 2-adrenoreceptor." Pharmacological Reviews. 1983;35(3):143-180.
- Lafontan M, Berlan M. "Fat cell adrenergic receptors and the control of white and brown fat cell function." Journal of Lipid Research. 1993;34(7):1057-1091.
- Callahan MF, et al. "Yohimbine and rauwolscine reduce food intake of genetically obese (ob/ob) and lean mice." Pharmacology Biochemistry and Behavior. 1984;20(4):591-599.
- World Anti-Doping Agency. "Prohibited List 2026." WADA-AMA.org. (Current list; yohimbine not included as of 2026.)
- National Sanitation Foundation. "NSF Certified for Sport Program." NSF.org.
- Informed Sport. "Informed Sport Testing Program." Informed-Sport.com.
Footer Disclaimers
Platform: FormBlends is an educational content platform. This page does not constitute medical advice and does not establish a clinician-patient relationship. Consult a qualified healthcare provider before starting any supplement regimen.
Research Compound: Yohimbine HCl is sold as a dietary supplement in the United States. It is not FDA-approved as a drug for any indication. Some formulations discussed may be regulated differently in other jurisdictions.
Results: Individual responses to yohimbine vary significantly. Published study outcomes reflect specific populations under controlled conditions and may not predict your individual results.
Trademark: All brand names, certification marks (NSF, Informed Sport, USP), and registered trademarks are the property of their respective owners. FormBlends has no commercial affiliation with any supplement manufacturer referenced on this page.